RIBOCICLIB

Clinical trials for RIBOCICLIB explained in plain language.

Never miss a new study

Get alerted when new RIBOCICLIB trials appear

Sign up with your email to follow new studies for RIBOCICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Breast cancer pill study: do patients stick with it?

Knowledge-focused Not yet recruiting

This study tracks 81 patients with early-stage, hormone-positive breast cancer who are prescribed a two- to three-year course of CDK4/6 inhibitor pills (abemaciclib or ribociclib) after surgery. The goal is to see how many stop taking the pills early and why. Researchers hope to …

Matched conditions: RIBOCICLIB

Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused

Last updated May 11, 2026 20:39 UTC

RIBOCICLIB

Get alerted when new RIBOCICLIB trials appear

Breast cancer pill study: do patients stick with it?